Preliminary Timetable

(1)

Preliminary Timetable

Wednesday, 6 October 2021

Hall 1

15:00 – 16:30

Plenary 1

When should we use the new drugs in lupus nephritis? Voclosporin Bred H Rovin, US Belimumab F Houssiau, Belgium Obinutuzumab R Furie, USA

Panel discussion: Bred H Rovin, USA; F Houssiau, Belgium; R Furie, USA; Maria Dall’Era, USA; T M Chan, China; CC Mok, China; David Jayne, UK

16:30 – 16:45

Short break

16:45 – 17:45

_{Industry Symposium}

17:45 – 18:00

Short break

18:00 – 19:30

Opening Ceremony & Keynote Lecture Welcome to LUPUS 2021

Welcome to CORA 2021 Keynote lecture

(2)

Thursday, 7 October 2021

Hall 1 Hall 2 Hall 3 Hall 4 Hall 5

08:00-09:00

Meet the Professor 1

Meet the Professor 2

Meet the Professor 3

Workshop 1

Workshop 2

09:00-10:30

Plenary 2

The time has come to set up diagnostic criteria in SLE?

Yes

George Bertsias, Greece Vs.

No

Aringer Martin, Germany

10:30-11:00

Coffee Break, Exhibition & Poster Viewing

Short Oral Discussion

11:00-13:00

_{Parallel 1 SLE}

_{Parallel 2 SLE}

_{Parallel 3 SLE}

Parallel 1 (CORA)

Spondyolarthritis 1 Chairperson: Roberta Ramonda,

Italy Did the understanding and treatment of non-radiographic axSpA add anything to our management of spondylarthritis? • YES: nr-axSpA gave a new view

new drugs etc

Xenophon Baraliakos, Germany

Parallel 2 (CORA)

Spondyolarthritis 2 Chairperson: Roberto

Perricone, Italy Psoriatic arthritis joints or skin: which drives the treatment??

• Joints Ian Bruce, UK • Skin

(3)

• NO: we did not learn anything advanced axSpA is the same Dennis McGonagle, UK

13:00-14:15

Lunch Break, Exhibition & Poster Viewing

Short Oral Discussion

Industry Symposium

12:45-14:00

14:15-15:45

Plenary 3

When should targeted therapies be used in the treatment of lupus nephritis? Early in the disease course

Maria Dall’Era, USA Vs.

Only in refractory patients Brad Rovin, USA

16:00- 16:30

_{Industry Symposium}

16:30-17:00

Coffee Break, Exhibition & Poster Viewing

Short Oral Discussion

17:00-19:00

_{Parallel 4 SLE}

_{Parallel 5 SLE}

_{Parallel 6 SLE}

Parallel 3 (CORA)

Rheumatoid arthritis 1

Chairperson:

Carlomaurizio Montecucco (Italy), Does RA seropositivity counts in disease and therapeutic outcome? • YES: seropositive and

seronegative patients are

Parallel 4 (CORA)

Rheumatoid arthritis 2 Chairperson:Fabiola Atzeni

(Italy) Can Pain and Fatigue in RA patient. Are small molecules better than biologics?

(4)

different, respond to different therapies, have different clinical manifestations, even genetics Josef Smolen, Austria

• NO: they are the same Roberto Caporali, Italy

• YES: small molecules better Piercarlo Sarzi-Puttini, Italy • NO: biologics better

Daniel Aletaha, Austria

(5)

Friday, 8 October 2021

08:00-09:00

Meet the Professor 4

Meet the Professor 5

Meet the Professor 6

Workshop 3

Workshop 4

09:00-10:30

Plenary 4

How common is clinical remission in real life? Experiences from around the world

• Italy: Margherita Zen

• The Netherlands: Alexandre E. Voskuijl • USA: Michelle Petri

• Latin America: Manuel Francisco Urgate Gill • China: CC Mok

• Asia-Pacific: Mandana Nikpour

Panel discussion: Margherita Zen, Alexandre E. Voskuijl, Michelle Petri, Manuel Francisco Urgate Gill, CC Mok, Mandana Nikpour

10:30-11:00

Coffee Break, Exhibition & Poster Viewing

Short Oral Discussion

11:00-13:00

_{Parallel 7 SLE}

_{Parallel 8 SLE}

_{Parallel 9 SLE}

Parallel 5 (CORA)

Systemic sclerosis 1 Chairperson: Roberto Giacomelli,

Italy

Is it possible to determine which patients benefit most from nintedanib and which from immunosuppressants in SSc-ILD? • YES: Marco Matucci Cerinic, Italy • NO: Yannick Allanore, France

Parallel 6 (CORA)

Systemic sclerosis 2

Chairperson: Gabriella Szucs, Hungary Can we always distinguish PAH (group I) from group 3 PH in SSc patients?

• YES: Luc Mouthon, France • No: Dinesh Khanna, USA

(6)

13:00-14:15

Lunch Break, Exhibition & Poster Viewing

Short Oral Discussion

Industry Symposium

12:45-14:00

14:15-15:45

Plenary 5

Antimalarials are useful but rather weak medications for SLE

Yes, it is true

Ronald F. Vollenhoven, The Netherlands Vs.

No, it is not true

Nathalie Costedoat-Chalumeau, France

16:00- 16:30

_{Industry Symposium}

16:30-17:00

Coffee Break, Exhibition & Poster Viewing

Short Oral Discussion

17:00-19:00

_{Parallel 10 SLE}

_{Parallel 11 SLE}

_{Parallel 12 SLE}

Parallel 7 (CORA)

Sjögren syndrome Chairperson: Roberto Gerli, Italy Is salivary gland biopsy mandatory in Sjögren Syndrome?

• YES: Thomas Dörner, Germany • NO: Xavier Mariette, France

Parallel 8 (CORA)

Autoimmunity and autoinflammation 1 Chairperson: Gyorgy Nagy,

Hungary Can autoimmunity and autoinflammation be separated?

• YES: there are two endpoints, phenotypic

(7)

differences: Zoltán Szekanecz, Hungary • NO: there is no such

distinction: Carlo Chizzolini, Switzerland

(8)

Saturday, 9 October 2021

07:30-08:30

Meet the Professor 7

Meet the Professor 8

Meet the Professor 9

Workshop 5

Workshop 6

08:30-10:30

Plenary 6 Is it safe to withdrawn a low-dose-glucocorticoid in SLE patients in remission? Yes

Guillermo Ruiz-Irastorza, Spain Vs.

No

Zahir Amoura, France

10:30-11:00

Coffee Break, Exhibition & Poster Viewing

Short Oral Discussion

11:00-13:00

_{Parallel 13 SLE}

_{Parallel 14 SLE}

_{Parallel 15 SLE}

Parallel 9 (CORA)

Autoimmunity and autoinflammation 2

Chairperson: Maurizio Cutolo, Italy Can Silicone breast implant be considered safe?

• YES: Franco Bassetto, Italy • NO: Yehuda Shoenfeld, Israel

Parallel 10 (CORA)

COVID/Vaccination Carlo Chizzolini (Switzerland)

Chairperson: Annamaria Iagnocco, Italy Is post-COVID syndrome an autoimmune disease? • YES: Yehuda Shoenfeld,

Israel

(9)

13:00-14:00

Lunch Break, Exhibition & Poster Viewing

Short Oral Discussion

14:00-16:00

_{Parallel 16 SLE}

_{Parallel 17 SLE}

_{Parallel 18 SLE}

Parallel 11 (CORA)

COVID/Vaccination Chairperson: Howard Amital, Israel Can patients with AIDs be vaccinated and when?

Marc Bijl, The Netherlands Different types of COVID

vaccinations: are they all the same? TBA

Post COVID/vaccination syndrome: is it a reality?

TBA

Parallel 12 (CORA)

Vasculitis Chairperson: TBA Vasculitis: Is GCA and Takayasu the same?

• YES: the same Raashid Luqmani, UK • NO: differences between

GCA-TA

Carlo Salvarani, Italy